Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis

Area of Science:

• Dermatology
• Rheumatology
• Fibrotic Disorders

Background:

• Morphea, or localized scleroderma, is a rare fibrosing condition affecting skin and subcutaneous tissues.
• It is distinguished from systemic sclerosis by the lack of specific clinical and capillaroscopic findings.
• Patients may experience systemic symptoms and exhibit positive autoantibodies, despite localized tissue involvement.

Purpose of the Study:

• To elucidate the key characteristics and diagnostic differentiators of morphea.
• To highlight the typical clinical presentation and serological findings in morphea patients.
• To underscore the mesodermal origin of tissue involvement in morphea.

Main Methods:

• Clinical case review and differential diagnosis from systemic sclerosis.
• Analysis of characteristic symptoms including malaise, fatigue, arthralgias, and myalgias.
• Evaluation of autoantibody serologies and tissue distribution.

Main Results:

• Morphea is characterized by localized fibrotic changes, primarily in mesodermally derived tissues.
• Absence of sclerodactyly, Raynaud phenomenon, and nailfold capillary changes differentiates it from systemic sclerosis.
• Systemic symptoms and positive autoantibodies are common in morphea.

Conclusions:

• Morphea is a distinct entity within the spectrum of scleroderma, primarily affecting localized tissues.
• Understanding the differentiating features is crucial for accurate diagnosis and management.
• Further research into the pathogenesis, involving collagen dysregulation, is warranted.